Stock detail
Crispr Therapeutics (CRSP) stock price, chart, and key data
View Crispr Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Crispr Therapeutics
CRSP · XNAS
$52.18
-2.38%
-$1.27
Key metrics
52-week range
$3.75 - $8.00
Close price
$53.45
Market cap
$5.2B
P/E ratio
-56.86
Beta
1.49
About the company
Crispr Therapeutics Ag
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$73.58
8
Buy
/ 13
Recent calls
09/04/2026
Citi
Yigal Nochomovitz
Buy · Price target $88.00
08/31/2026
Needham
Gil Blum
Buy · Price target $82.00
08/31/2026
Evercore ISI
Jonathan Miller
Buy · Price target $76.00
Ticker holders
Review politician disclosures and insider transactions in tabs.
Holder directory
Select a heading to reorder by name, activity date, buy/sell, or displayed value.
#1Tom Suozzi democrat · House · NY-3 self |
| $150,003/$225,002/$300,000 |
#2Ashley Moody republican · Senate · FL self |
| 381/825/1,270 |
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app